Gensight Biologics S.A.
Gene therapy to treat inherited diseases of the eye and central nervous system
AI Overview
With $70K in lobbying spend across 3 quarterly filings, Gensight Biologics S.A is an active lobbying client. Their lobbying covers 2 issue areas.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $70K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy
Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused drug development
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.